AYTU BIOPHARMA, INC Amortization of Debt Issuance Costs and Discounts
AYTU BIOPHARMA, INC (AYTU) reported Amortization of Debt Issuance Costs and Discounts of $113.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-09-22
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $28.00K, a 7.69% increase year-over-year.
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $27.00K, a 0.00% change year-over-year.
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $29.00K, a 3.57% increase year-over-year.
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $29.00K, a 7.41% increase year-over-year.
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for fiscal 2026 was $113.00K, a 4.63% increase from fiscal 2025.
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for fiscal 2025 was $108.00K, a 81.91% decline from fiscal 2024.
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for fiscal 2024 was $597.00K, a 6.80% increase from fiscal 2023.
- AYTU BIOPHARMA, INC amortization of debt issuance costs and discounts for fiscal 2023 was $559.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $55.00K derived: sum of 2 quarters · filed 2026-09-22 | $84.00K derived: sum of 3 quarters · filed 2026-09-22 | $113.00K 10-K · filed 2026-09-22 | |
| 2026-03-31 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $56.00K derived: sum of 2 quarters · filed 2026-05-13 | $85.00K 10-Q · filed 2026-05-13 | $111.00K derived: sum of 4 quarters · filed 2026-09-22 | |
| 2025-12-31 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $58.00K 10-Q · filed 2026-02-03 | $84.00K derived: sum of 3 quarters · filed 2026-09-22 | $111.00K derived: sum of 4 quarters · filed 2026-09-22 | |
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-13 | $55.00K derived: sum of 2 quarters · filed 2026-09-22 | $82.00K derived: sum of 3 quarters · filed 2026-09-22 | $110.00K derived: sum of 4 quarters · filed 2026-09-22 | |
| 2025-06-30 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $53.00K derived: sum of 2 quarters · filed 2026-09-22 | $81.00K derived: sum of 3 quarters · filed 2026-09-22 | $108.00K 10-K · filed 2026-09-22 | |
| 2025-03-31 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $55.00K derived: sum of 2 quarters · filed 2026-05-13 | $82.00K 10-Q · filed 2026-05-13 | $216.00K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $55.00K 10-Q · filed 2026-02-03 | $189.00K derived: sum of 3 quarters · filed 2026-02-03 | $350.00K derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-09-30 | $27.00K 10-Q · filed 2025-11-13 | $161.00K derived: sum of 2 quarters · filed 2025-11-13 | $27.00K 10-Q · filed 2024-11-13 | $476.00K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $295.00K derived: sum of 2 quarters · filed 2025-09-23 | $449.00K derived: sum of 3 quarters · filed 2025-09-23 | $597.00K 10-K · filed 2025-09-23 | |
| 2024-03-31 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $315.00K derived: sum of 2 quarters · filed 2025-05-14 | $463.00K 10-Q · filed 2025-05-14 | $609.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | $302.00K 10-Q · filed 2025-02-12 | $448.00K derived: sum of 3 quarters · filed 2025-02-12 | $546.00K derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-09-30 | $148.00K 10-Q · filed 2023-11-14 | $294.00K derived: sum of 2 quarters · filed 2024-09-26 | $148.00K 10-Q · filed 2024-11-13 | $562.00K derived: sum of 4 quarters · filed 2024-09-26 | |
| 2023-06-30 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $244.00K derived: sum of 2 quarters · filed 2024-09-26 | $414.00K derived: sum of 3 quarters · filed 2024-09-26 | $559.00K 10-K · filed 2024-09-26 | |
| 2023-03-31 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $268.00K derived: sum of 2 quarters · filed 2024-05-15 | $413.00K 10-Q · filed 2024-05-15 | $555.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $315.00K 10-Q · filed 2024-02-14 | $457.00K derived: sum of 3 quarters · filed 2024-02-14 | $515.00K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $145.00K 10-Q · filed 2023-11-14 | $287.00K derived: sum of 2 quarters · filed 2023-11-14 | $345.00K derived: sum of 3 quarters · filed 2023-11-14 | $180.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $200.00K derived: sum of 2 quarters · filed 2023-10-12 | $35.00K derived: sum of 3 quarters · filed 2023-10-12 | -$126.00K 10-K · filed 2023-10-12 | |
| 2022-03-31 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$107.00K derived: sum of 2 quarters · filed 2023-05-11 | -$268.00K 10-Q · filed 2023-05-11 | -$427.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$165.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | -$326.00K 10-Q · filed 2023-02-21 | -$485.00K derived: sum of 3 quarters · filed 2023-02-21 | -$502.00K derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-09-30 | -$161.00K 10-Q/A · filed 2023-02-21 | -$320.00K derived: sum of 2 quarters · filed 2023-02-21 | -$337.00K derived: sum of 3 quarters · filed 2023-02-21 | -$290.00K derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$176.00K derived: sum of 2 quarters · filed 2022-09-27 | -$129.00K derived: sum of 3 quarters · filed 2022-09-27 | -$44.00K 10-K · filed 2022-09-27 | |
| 2021-03-31 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $30.00K derived: sum of 2 quarters · filed 2022-05-16 | $115.00K 10-Q · filed 2022-05-16 | -$21.92K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $132.00K 10-Q · filed 2022-02-14 | |||
| 2020-09-30 | $85.00K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $532.00K 10-K · filed 2021-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |